Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print February 6, 2004
Mol. Biol. Cell 10.1091/mbc.E03-12-0873

A more recent version of this article appeared on April 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E03-12-0873v1
15/4/1600    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittenmayer, N.
Right arrow Articles by Jockusch, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittenmayer, N.
Right arrow Articles by Jockusch, B. M.

Submitted on December 5, 2003
Revised on January 7, 2004
Accepted on January 8, 2004

The Tumor Suppressor Activity of Profilin Requires a Functional Actin Binding Site

Nina Wittenmayer1, Burkhard Jandrig2, Martin Rothkegel1, Kathrin Schlüter3, Wolfgang Arnold4, Wolfgang Haensch5, Siegfried Scherneck2, and Brigitte M. Jockusch1*

1 Cell Biology, Zoological Institute, Technical University of Braunschweig, D-38092 Braunschweig, Germany
2 Tumor Genetics, Max-Delbrück-Center for Molecular Medicine, D-13092 Berlin-Buch, Germany
3 Cell Biology, Zoological Institute, Technical University of Braunschweig, D-38092 Braunschweig, Germany, BD Biosciences, D-69126 Heidelberg, Germany
4 atugen AG, D-13125 Berlin-Buch, Germany
5 Clinic of Surgery and Surgical Oncology, Robert Rössle Hospital, D-13122 Berlin-Buch, Germany

* Corresponding author. E-mail address: bmj{at}tu-bs.de.

Profilin 1 (PFN1) is a regulator of the microfilament system and involved in various signaling pathways. It interacts with many cytoplasmic and nuclear ligands. The importance of PFN1 for human tissue differentiation has been demonstrated by the findings that human cancer cells, expressing conspicuously low PFN1 levels, adopt a nontumorigenic phenotype upon raising their PFN1 level. In the present study, we characterize the ligand binding site crucial for profilin’s tumor suppressor activity. Starting with CAL51, a human breast cancer cell line highly tumorigenic in nude mice, we established stable clones that express PFN1 mutants differentially defective in ligand binding. Clones expressing PFN1 mutants with reduced binding to either poly-proline-stretch ligands or phosphatidyl-inositol-4,5-bisphosphate, but with a functional actin-binding site, were normal in growth, adhesion and anchorage dependence, with only a weak tendency to elicit tumors in nude mice, similar to controls expressing wild-type PFN1. In contrast, clones expressing a mutant with severely reduced capacity to bind actin still behaved like the parental CAL51 and was highly tumorigenic. We conclude that the actin-binding site on profilin is instrumental for normal differentiation of human epithelia and the tumor suppressor function of PFN1.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
J. Shao, W. J. Welch, N. A. DiProspero, and M. I. Diamond
Phosphorylation of Profilin by ROCK1 Regulates Polyglutamine Aggregation
Mol. Cell. Biol., September 1, 2008; 28(17): 5196 - 5208.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.